General MedicationsINJECTIONStandard
ROPIVACAINE HYDROCHLORIDE
ROPIVACAINE HYDROCHLORIDE
Standard Dose
20MG/10ML (2MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ROPIVACAINE HYDROCHLORIDE is listed in Drugs@FDA under application 219883 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ROPIVACAINE HYDROCHLORIDE Form and strength SOLUTION;INJECTION - 20MG/10ML (2MG/ML) Sponsor ANTHEA PHARMA Submission history Latest submission status date: 2025-03-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview ROPIVACAINE HYDROCHLORIDE is listed in Drugs@FDA under application 219883 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ROPIVACAINE HYDROCHLORIDE Form and strength SOLUTION;INJECTION - 20MG/10ML (2MG/ML) Sponsor ANTHEA PHARMA Submission history Latest submission status date: 2025-03-21 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.